News

Gefitinib Offers Palliative Care in Advanced Esophageal Cancer


 

AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY CONGRESS

Cancer Research UK sponsored the trial. Dr. Ferry reported grant support, honoraria, and an advisory relationship with AstraZeneca in the development of gefitinib.

Pages

Next Article:

Second TNF-Blocker Approved for Refractory Ulcerative Colitis